1226666

Daito Pharmaceutical Co., Ltd. — FEI 3002806779

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 19, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Toyama (Japan)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
360321 CFR 211.160(b)Scientifically sound laboratory controls